Kezar Life Sciences, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €0.00 -100.0% -€72.23M -17.8% N/A -€63.99M -7.1% N/A
    €6.04M +∞% -€87.87M +56.0% -1,455.3% -15 pp -€68.86M +39.4% -1,140.5% -11 pp
    €0.00 +NaN% -€56.34M +22.6% N/A -€49.40M +36.0% N/A
    €0.00 +NaN% -€45.96M +36.6% N/A -€36.33M +14.6% N/A
    €0.00 +NaN% -€33.63M +23.7% N/A -€31.70M +25.6% N/A
    €0.00 +NaN% -€27.20M +36.1% N/A -€25.25M +48.8% N/A
    €0.00 +NaN% -€19.98M +172.0% N/A -€16.97M +154.8% N/A
    €0.00 +NaN% -€7.35M -5.3% N/A -€6.66M -19.8% N/A
    €0.00 -€7.75M N/A -€8.31M N/A

    Notifications